Freeline Completes 1-For-15 ADS Ratio Change
Freeline Therapeutics Holdings plc (NASDAQ:FRLN) today announced that the company's previously disclosed change to its American Depositary Share ("ADS") to ordinary share ratio has been made
Aspira Women’s Health Announces 1-For-15 Reverse Stock Split
Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic, tools, today announced a 1-for-15
Venus Concept Announces 1-for-15 Reverse Stock Split
Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that its Board of Directors approved a 1-for-15 reverse stock split
Vinco Ventures, Inc. Announces 1-For-20 Reverse Stock Split
Vinco Ventures, Inc. (NASDAQ:BBIG) ("Vinco Ventures," "Vinco," or the "Company"), a digital media and content technologies company, announced that on May 4, 2023 it filed a Certificate of
Hepion Pharmaceuticals, Inc. Announces 1-For-20 Reverse Stock Split
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence ("AI")-driven therapeutic drug development for the treatment of fibrotic diseases,
ReTo Eco-Solutions, Inc. Announces 10-For-1 Share Combination; Will Begin Trading On A Split Adjusted Basis On May 12, 2023
ReTo Eco-Solutions, Inc. (NASDAQ:RETO) ("ReTo" or the "Company"), a provider of technology solutions and operation services for intelligent ecological environments and roadside assistance services and
Tonix Pharmaceuticals Announces 1-For-6.25 Reverse Stock Split
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it will effect a 1-for-6.25 reverse stock split of its outstanding common stock.
Medalist Diversified REIT, Inc. Announces Effectiveness Of 1-For-8 Reverse Stock Split
Medalist Diversified REIT, Inc. (NASDAQ:MDRR) (the "Company" or "Medalist"), a Virginia-based real estate investment trust that specializes in acquiring, owning and managing value-add commercial real estate in the
Plus Therapeutics Announces 1-For-15 Reverse Stock Split
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today
Vislink Technologies, Inc. Announces 1-For-20 Reverse Stock Split As Part Of Nasdaq Compliance Plan
Vislink Technologies, Inc. (NASDAQ:VISL) ("Vislink" or the "Company"), today announced that it will effect a 1-for-20 reverse stock split ("Reverse Split") of its common